Indacaterol 125micrograms/dose / Mometasone 127.5micrograms/dose inhalation powder capsules with device

in short Indacaterol 125microg/Mometasone 127.5microg/dose pdr caps

SNOMED code
39116311000001103
Active compound
Indacaterol + Mometasone
Preferred name basis
Other
Prescribable
✅ Yes
Non-availability
Actual Products not Available
Non-availability date
Dose form
Discrete
Dose size and units
1 capsule, capsule
Ingredients
Indacaterol acetate, ID: 702801003 — 125 microgram / 1 dose based on base substance
Mometasone furoate — 127.5 microgram / 1 dose based on ingredient substance
Form & Route
powderinhalation.inhalation
Inhalation powder, Inhalation
Controlled drug
No Controlled Drug Status

Products

Atectura Breezhaler 125micrograms/127.5micrograms inhalation powder capsules with device (Novartis Pharmaceuticals UK Ltd)

in short Atectura Breezhaler 125microg/127.5microg pdr caps

Atectura Breezhaler 125micrograms/127.5micrograms inhalation powder capsules with device

SNOMED code
39115411000001101
Supplier
Novartis Pharmaceuticals UK Ltd
Licensed as
Medicines - MHRA/EMA
Availability restrictions
Not available
Licensed route
Inhalation
Pack name & codeStatusGTIN, EAN barcodesPricePrescribingReimbursementPack
Atectura Breezhaler 125micrograms/127.5micrograms inhalation powder capsules with device (Novartis Pharmaceuticals UK Ltd) 30 capsule 3 x 10 capsules
39115511000001102   ref. pack
Discontinued


Legal category: POM
07613421042257
NHS Indicative Price
£21.50
  • • Prescription Charges
  • • Dispensing Fees
  • • Special container

Reference packs

Indacaterol 125micrograms/dose / Mometasone 127.5micrograms/dose inhalation powder capsules with device 30 capsule
SNOMED code
39115211000001100
Quantity and unit
30 capsule
Packs